US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Shield Therapeutics PLC

0.1413

+0.00715.29%

Volume:10.00K

Turnover:1.41K

Market Cap:150.88M

PE:-6.07

High:0.1413

Open:0.1413

Low:0.1413

Close:0.1342

52wk High:0.1512

52wk Low:0.0331

Shares:1.07B

Float Shares:1.04B

Volume Ratio:3.68

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0233

EPS(LYR):-0.0306

ROE:-396.35%

ROA:-16.77%

PB:-10.16

PE(LYR):-4.61

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Shield Therapeutics PLC

Exchange:

OTCQB

Establishment Date:

2008

Employees:

63

Office Location:

Northern Design Centre,Baltic Business Quarter,Gateshead,Tyne and Wear,United Kingdom

Website:

- -

Zip Code:

NE8 3DF

Phone:

44 1915 118 500

Fax:

- -

Introduction:

Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SHIEF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"SHIEF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHIEF\",,,,,undefined,":{"symbol":"SHIEF","market":"US","secType":"STK","nameCN":"Shield Therapeutics PLC","latestPrice":0.1413,"timestamp":1771621200000,"preClose":0.1342,"halted":0,"volume":10000,"delay":15,"changeRate":0.052906110283159426,"floatShares":1041690484,"shares":1067828251,"eps":-0.023273,"marketStatus":"Market Closed","change":0.0071,"latestTime":"02-20 16:00:00 EST Delay","open":0.1413,"high":0.1413,"low":0.1413,"amount":1413,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.023273,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"OTCQB","adjPreClose":0.1342,"volumeRatio":3.6764705747188584},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHIEF\",,,,,undefined,":{"symbol":"SHIEF","floatShares":1041690484,"roa":"-16.77%","roe":"-396.35%","lyrEps":-0.030628,"volumeRatio":3.6764705747188584,"shares":1067828251,"dividePrice":0,"high":0.1413,"amplitude":0,"preClose":0.1342,"low":0.1413,"week52Low":0.0331,"pbRate":"-10.16","psRate":"3.64","week52High":0.15115,"institutionHeld":0,"latestPrice":0.1413,"eps":-0.023273,"divideRate":0,"volume":10000,"delay":15,"ttmEps":-0.023273,"open":0.1413,"prevYearClose":0.146,"prevWeekClose":0.149,"prevMonthClose":0.14,"prevQuarterClose":0.146,"fiveDayClose":0.149,"twentyDayClose":0.1476,"sixtyDayClose":0.0901},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SHIEF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-04","symbol":"SHIEF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1725422400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-04-30","symbol":"SHIEF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714449600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2022-06-30","symbol":"SHIEF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1656561600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SHIEF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SHIEF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1769835600000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":115221091,"yearFounded":2008,"employeeNum":63,"address":"Northern Design Centre,Baltic Business Quarter,Gateshead,Tyne and Wear,United Kingdom","zipCode":"NE8 3DF","officePhone":"44 1915 118 500"},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"ytd","weight":0}],"description":"Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.","exchange":"OTCQB","name":"Shield Therapeutics PLC","nameEN":"Shield Therapeutics PLC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SHIEF\",market:\"US\",,,undefined,":null}}